Management of Venous Thromboembolism in Patients with Advanced Gastrointestinal Cancers: What Is the Role of Novel Oral Anticoagulants?

Table 1

Incidence of VTE in patients with gastrointestinal cancers.

Primary site	VTE incidence; (per 100 person-years/% of patients)
Gastroesophageal [6–9]	50/7–14
Pancreas [6–10]	20/5–60
Colorectal and anal [7–9, 11]	13.7/3–10
Hepatobiliary [7, 9, 12, 13]	4.6/2–15